Beesetti S, Guy C, Sirasanagandla S, Yang M, Sumpter R, Sheppard H
Cell Death Differ. 2025; .
PMID: 39962244
DOI: 10.1038/s41418-025-01461-3.
Liu Y, Luo Y, Wang P, Li W, Tian H, Cao C
Commun Biol. 2024; 7(1):1513.
PMID: 39543266
PMC: 11564879.
DOI: 10.1038/s42003-024-07126-0.
Li J, Jia Z, Dong L, Cao H, Huang Y, Xu H
Biomark Res. 2024; 12(1):111.
PMID: 39334297
PMC: 11437670.
DOI: 10.1186/s40364-024-00653-2.
Li S, Tang M, Xiong Y, Feng X, Wang C, Nie L
Oncogene. 2024; 43(35):2621-2634.
PMID: 39068216
DOI: 10.1038/s41388-024-03108-y.
Berckmans Y, Ene H, Ben-Meir K, Martinez-Conde A, Wouters R, Van den Ende B
Front Oncol. 2024; 14:1402851.
PMID: 38993641
PMC: 11238040.
DOI: 10.3389/fonc.2024.1402851.
Dual role of proliferating cell nuclear antigen monoubiquitination in facilitating Fanconi anemia-mediated interstrand crosslink repair.
Shah R, Aslam M, Spanjaard A, de Groot D, Zurcher L, Altelaar M
PNAS Nexus. 2024; 3(7):pgae242.
PMID: 38957451
PMC: 11217772.
DOI: 10.1093/pnasnexus/pgae242.
STIL facilitates the development and malignant progression of triple-negative breast cancer through activation of Fanconi anemia pathway via interacting with KLF16.
Wang M, Pan B, Hu Y, Gao J, Hou L, Yu Z
Transl Oncol. 2024; 46:102010.
PMID: 38823260
PMC: 11177054.
DOI: 10.1016/j.tranon.2024.102010.
Therapeutic targeting of ARID1A-deficient cancer cells with RITA (Reactivating p53 and inducing tumor apoptosis).
Wang Z, Zhang X, Luo Y, Song Y, Xiang C, He Y
Cell Death Dis. 2024; 15(5):375.
PMID: 38811536
PMC: 11136964.
DOI: 10.1038/s41419-024-06751-1.
Therapeutic Targeting of DNA Repair Pathways in Pediatric Extracranial Solid Tumors: Current State and Implications for Immunotherapy.
Zhao S, Prior D, Heske C, Vasquez J
Cancers (Basel). 2024; 16(9).
PMID: 38730598
PMC: 11083679.
DOI: 10.3390/cancers16091648.
Crosstalk between DNA Damage Repair and Metabolic Regulation in Hematopoietic Stem Cells.
Xu J, Fei P, Simon D, Morowitz M, Mehta P, Du W
Cells. 2024; 13(9.
PMID: 38727270
PMC: 11083014.
DOI: 10.3390/cells13090733.
Poly(ADP-ribosyl)ation of TIMELESS limits DNA replication stress and promotes stalled fork protection.
Rageul J, Lo N, Phi A, Patel J, Park J, Kim H
Cell Rep. 2024; 43(3):113845.
PMID: 38393943
PMC: 11029348.
DOI: 10.1016/j.celrep.2024.113845.
The emergence of Fanconi anaemia type S: a phenotypic spectrum of biallelic mutations.
Hughes T, Rose A
Front Oncol. 2023; 13:1278004.
PMID: 38146508
PMC: 10749362.
DOI: 10.3389/fonc.2023.1278004.
Targeting the DNA Damage Response for Cancer Therapy.
Wang R, Sun Y, Li C, Xue Y, Ba X
Int J Mol Sci. 2023; 24(21).
PMID: 37958890
PMC: 10648182.
DOI: 10.3390/ijms242115907.
The Spectrum of Germline Nucleotide Variants in Gastric Cancer Patients in the Kyrgyz Republic.
Bilyalov A, Nikolaev S, Danishevich A, Khatkov I, Makhmudov K, Isakova Z
Curr Issues Mol Biol. 2023; 45(8):6383-6394.
PMID: 37623222
PMC: 10453583.
DOI: 10.3390/cimb45080403.
A comprehensive analysis of Fanconi anemia genes in Chinese patients with high-risk hereditary breast cancer.
Zhu Q, Li P, Zhu Y, Pan J, Wang R, Li X
J Cancer Res Clin Oncol. 2023; 149(15):14303-14313.
PMID: 37566130
PMC: 10590287.
DOI: 10.1007/s00432-023-05236-6.
Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines.
Fishman H, Monin R, Dor-On E, Kinzel A, Haber A, Giladi M
J Neurooncol. 2023; 163(1):83-94.
PMID: 37131108
PMC: 10232578.
DOI: 10.1007/s11060-023-04308-4.
ShrinkCRISPR: a flexible method for differential fitness analysis of CRISPR-Cas9 screen data.
Tissier R, van Schie J, Wolthuis R, de Lange J, Menezes R
BMC Bioinformatics. 2023; 24(1):36.
PMID: 36732720
PMC: 9896759.
DOI: 10.1186/s12859-023-05142-1.
Association of environmental exposure to chromium with differential DNA methylation: An epigenome-wide study.
Zhao M, Wu J, Xu J, Li A, Mei Y, Ge X
Front Genet. 2023; 13:1043486.
PMID: 36685967
PMC: 9845398.
DOI: 10.3389/fgene.2022.1043486.
Planispine A Sensitized Cancer Cells to Cisplatin by Inhibiting the Fanconi Anemia Pathway.
Singh T, Singh N, Devi K, Meiguilungpou R, Khongsai L, Singh L
Molecules. 2022; 27(21).
PMID: 36364114
PMC: 9654912.
DOI: 10.3390/molecules27217288.
Leveraging the replication stress response to optimize cancer therapy.
Cybulla E, Vindigni A
Nat Rev Cancer. 2022; 23(1):6-24.
PMID: 36323800
PMC: 9789215.
DOI: 10.1038/s41568-022-00518-6.